InMed files prospectus supplement for ATM offering of common shares under existing Sales Agreement

InMed Pharmaceuticals Inc.

Filed prospectus supplement dated April 3, 2026 for at-the-market equity offering.
ATM facility is under Sales Agreement with H.C. Wainwright & Co., originally dated April 7, 2022, amended June 27, 2024.
Shelf registration statement on Form S-3 (File No. 333-294503) declared effective March 30, 2026.
No specific number of shares or dollar amount disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.